Accounts Payable and Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2017

Accounts Payable and Accrued Liabilities [Abstract]

Accounts payable and accrued liabilities

At September 30, 2017 and December 31, 2016, accounts payable and accrued liabilities consisted of the following (in thousands):

	September 30, 2017 (unaudited)(1)		December 31, 2016
Accounts payable	$	508	$	1,593
Accrued expenses		2,775		3,212
Accrued compensation		1,782		1,904
Other current liabilities		295		435
Total	$	5,360	$	7,144

⁽¹⁾ Reflects the effect of the OncoCyte Deconsolidation.